chr12-114683140-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_005996.4(TBX3):​c.61C>T​(p.Leu21Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00848 in 1,612,724 control chromosomes in the GnomAD database, including 75 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0064 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0087 ( 69 hom. )

Consequence

TBX3
NM_005996.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.68

Publications

3 publications found
Variant links:
Genes affected
TBX3 (HGNC:11602): (T-box transcription factor 3) This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This protein is a transcriptional repressor and is thought to play a role in the anterior/posterior axis of the tetrapod forelimb. Mutations in this gene cause ulnar-mammary syndrome, affecting limb, apocrine gland, tooth, hair, and genital development. Alternative splicing of this gene results in three transcript variants encoding different isoforms; however, the full length nature of one variant has not been determined. [provided by RefSeq, Jul 2008]
TBX3-AS1 (HGNC:55471): (TBX3 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 12-114683140-G-A is Benign according to our data. Variant chr12-114683140-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 307378.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.68 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00641 (977/152304) while in subpopulation NFE AF = 0.0104 (706/68026). AF 95% confidence interval is 0.00974. There are 6 homozygotes in GnomAd4. There are 436 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 977 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TBX3NM_005996.4 linkc.61C>T p.Leu21Leu synonymous_variant Exon 1 of 7 ENST00000349155.7 NP_005987.3 O15119-2A0A024RBQ4
TBX3NM_016569.4 linkc.61C>T p.Leu21Leu synonymous_variant Exon 1 of 8 NP_057653.3 O15119-1A0A024RBL6
TBX3-AS1NR_187552.1 linkn.343+506G>A intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TBX3ENST00000349155.7 linkc.61C>T p.Leu21Leu synonymous_variant Exon 1 of 7 1 NM_005996.4 ENSP00000257567.2 O15119-2

Frequencies

GnomAD3 genomes
AF:
0.00639
AC:
973
AN:
152186
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00420
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00334
Gnomad ASJ
AF:
0.00462
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00132
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0104
Gnomad OTH
AF:
0.00382
GnomAD2 exomes
AF:
0.00607
AC:
1503
AN:
247688
AF XY:
0.00599
show subpopulations
Gnomad AFR exome
AF:
0.00348
Gnomad AMR exome
AF:
0.00356
Gnomad ASJ exome
AF:
0.00351
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00125
Gnomad NFE exome
AF:
0.0108
Gnomad OTH exome
AF:
0.00625
GnomAD4 exome
AF:
0.00869
AC:
12693
AN:
1460420
Hom.:
69
Cov.:
31
AF XY:
0.00851
AC XY:
6183
AN XY:
726404
show subpopulations
African (AFR)
AF:
0.00320
AC:
107
AN:
33452
American (AMR)
AF:
0.00421
AC:
188
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.00321
AC:
84
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39684
South Asian (SAS)
AF:
0.000812
AC:
70
AN:
86238
European-Finnish (FIN)
AF:
0.00139
AC:
73
AN:
52560
Middle Eastern (MID)
AF:
0.00494
AC:
28
AN:
5666
European-Non Finnish (NFE)
AF:
0.0106
AC:
11760
AN:
1111658
Other (OTH)
AF:
0.00633
AC:
382
AN:
60322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
826
1653
2479
3306
4132
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
424
848
1272
1696
2120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00641
AC:
977
AN:
152304
Hom.:
6
Cov.:
32
AF XY:
0.00585
AC XY:
436
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.00428
AC:
178
AN:
41572
American (AMR)
AF:
0.00333
AC:
51
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00462
AC:
16
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00132
AC:
14
AN:
10620
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0104
AC:
706
AN:
68026
Other (OTH)
AF:
0.00378
AC:
8
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
50
101
151
202
252
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00878
Hom.:
5
Bravo
AF:
0.00679
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00927
EpiControl
AF:
0.00966

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TBX3: BP4, BP7, BS1, BS2; TBX3-AS1: BS1, BS2 -

Nov 03, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Ulnar-mammary syndrome Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
14
DANN
Benign
0.94
PhyloP100
2.7
PromoterAI
0.017
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142592809; hg19: chr12-115120945; API